Skip to main content

Table 1 Characteristics of the included studies

From: Clinical outcome comparison of percutaneous coronary intervention and bypass surgery in diabetic patients with coronary artery disease: a meta-analysis of randomized controlled trials and observational studies

Study

Year

Follow-up years

Samples P/C

Age, years P/C

Male, % P/C

HTN, % P/C

Smoke, % P/C

Dsl, % P/C

Stent type

Study design

Coronary lesion

Kapur et al. [21]

2010

1

172/178

64.3/63.6

70.7/77.9

20.8/18.7

24.6/23.2

NA

DES

RCT

MVD (2- or 3-vessel disease)

Luo et al. [24]

2012

3

99/127

65/66

70/98

72/87

43.0/54.0

15.0/31.0

DES

OS

Unprotected LM disease (and/or 1-, 2-, or 3-vessel coronary disease)

Farkouh et al. [5]

2012

1

953/947

63.2/63.1

73.2/69.5

NA

14.8/16.6

NA

SES or PES

RCT

MVD with stenosis of more than 70% in 2 or more major epicardial vessels

Kamalesh et al. [8]

2013

2

101/97

62.7/62.1

99.0/99.0

96.0/95.7

27.7/20.6

NA

DES

RCT

MVD (2- or 3-vessel disease)

Kappetein et al. [9]

2013

5

231/221

NA

NA

NA

NA

NA

PES

RCT

LM and/or 3-vessel disease

Ben-Gal et al. [23]

2015

1

1349/423

65.0/65.0

73.0/66.3

79.4/85.9

21.0/24.0

61.8/72.7

DES

RCT

LM and/or 2-, 3-vessel disease

Bangalore et al. [25, 34]

2015

4

773/773

64.9/64.7

68.0/68.0

NA

NA

NA

EES

OS

MVD (2-, 3-vessel disease and without LM)

Marui et al. [26]

2015

5

1065/933

68.7/67.8

68.0/73.0

88.0/84.0

25.0/25.0

NA

DES

OS

LM and/or 3-vessel disease

Ahn et al. [22]

2015

5

102/90

NA

NA

NA

NA

NA

SES

RCT

Unprotected LM disease with stenosis of more than 50%

Naito et al. [27]

2015

3.8

256/227

72.7/72.7

78.1/68.3

77.0/74.0

58.6/62.6

76.6/68.7

DES

OS

LM and/or 2-, 3-vessel disease

Yu et al. [28]

2015

7.1

143/131

65.0/66.0

72.0/77.9

68.5/65.6

49.7/45.8

53.8/37.4

DES

OS

Unprotected LM and 1-, 2-, or 3-vessel coronary disease

Zheng et al. [29]

2016

3

348/806

NA

NA

NA

NA

NA

DES

OS

LM and/or 1-, 2-, 3-vessel disease

Li et al. [30]

2017

10

406/406

41.9/42.0

366/369

60.8/63.5

66.0/65.3

NA

DES

OS

LM and/or 1-, 2-, 3-vessel disease

Ramanathan et al. [11]

2017

5

2710/1865

67.3/65.2

72.0/73.2

88.1/91.8

NA

77.5/79.5

DES

OS

MVD with stenosis of more than 70% in 2 or more major epicardial vessels

Nagendran et al. [31]

2018

5

869/869

65.1/65.1

23.0/21.0

83.0/85.0

18.0/20.0

80.0/82.0

DES

OS

LM and/or 2-, 3-vessel disease

Milojevic et al. [14]

2019

3

286/268

NA

NA

NA

NA

NA

EES

RCT

LM and/or 1-, 2-, or 3-vessel coronary disease

  1. HTN hypertension, Dsl dyslipidemia, P/C percutaneous coronary intervention versus coronary artery bypass surgery, DES drug-eluting stents, but type of the stents is not available, SES sirolimus-eluting stent, PES paclitaxel-eluting stent, EES everolimus-eluting stent, MVD multivessel disease, LM left main, RCT randomized controlled trials, OS observational studies, NA not available